We are live on ! Find out more
RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

77 hedge funds and large institutions have $379M invested in Repros Therapeutics Inc. in 2014 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $379M → $379M (+$376K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 80 → 77 (-3)

14% less call options, than puts

Call options by funds: $9.62M | Put options by funds: $11.2M

24% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 29

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

Holders
77
Holders Change
-3
Holders Change %
-3.75%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
22
Reduced
29
Closed
12
Calls
$9.62M
Puts
$11.2M
Net Calls
-$1.56M
Net Calls Change
+$543K

Top Buyers

Rank Fund Capital Flow
1
SCM
Sarissa Capital Management
Connecticut
+$7.22M
2
CCM
Camber Capital Management
Massachusetts
+$6.36M
3
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
+$5.38M
4
Franklin Resources
Franklin Resources
California
+$4.24M
5
DCM
Destrier Capital Management
New York
+$3.6M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$4.3M
2
RCM
RA Capital Management
Massachusetts
-$3.58M
3
QF
QVT Financial
New York
-$2.96M
4
State Street
State Street
Massachusetts
-$2.7M
5
WC
Wexford Capital
Florida
-$2.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$2.02M -$101K -6,168 -5%
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$1.74M +$1.63M +100,268 New
TCIM
28
TIAA CREF Investment Management
New York
$1.73M -$17.1K -1,046 -1%
KCM
29
Kingdon Capital Management
New York
$1.6M -$902K -55,300 -37%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$1.58M -$362K -22,227 -20%
DCM
31
Driehaus Capital Management
Illinois
$1.28M -$38.4K -2,353 -3%
BIM
32
BlackRock Investment Management
Delaware
$1.17M +$63.3K +3,884 +6%
SM
33
Sabby Management
Florida
$1.14M +$1.08M +65,978 New
Nomura Holdings
34
Nomura Holdings
Japan
$1.13M +$3.18K +195 +0.3%
Allianz Asset Management
35
Allianz Asset Management
Germany
$967K -$5.12K -314 -0.6%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$934K – – –
Citigroup
37
Citigroup
New York
$904K -$112K -6,858 -12%
Goldman Sachs
38
Goldman Sachs
New York
$895K -$618K -37,935 -42%
TMC
39
Trellus Management Company
Florida
$865K – – –
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$794K -$1.35M -82,862 -64%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$728K +$4.89K +300 +0.7%
AllianceBernstein
42
AllianceBernstein
Tennessee
$621K – – –
MOACM
43
Mutual of America Capital Management
New York
$600K +$160K +9,801 +39%
Charles Schwab
44
Charles Schwab
California
$566K – – –
PIM
45
Partner Investment Management
California
$563K -$189K -11,580 -26%
TA
46
Teachers Advisors
New York
$554K -$35K -2,147 -6%
Dimensional Fund Advisors
47
Dimensional Fund Advisors
Texas
$458K – – –
Swiss National Bank
48
Swiss National Bank
Switzerland
$457K – – –
PP
49
PDT Partners
New York
$453K +$427K +26,205 New
CS
50
Credit Suisse
Switzerland
$397K +$43.2K +2,650 +13%
1
2
3 4

RPRX Hedge Fund Activity: Q2 2014 in Review

77 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q2 2014, worth a combined $379M — up 0.1% from $379M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of RPRX and 9 opened new positions — a net loss of 3 holders — while 29 trimmed existing stakes and 22 added.

The largest buyer was Sarissa Capital Management, adding an estimated $7.22M. The largest seller was PFM Health Sciences, cutting an estimated $4.3M.

  • 77 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q2 2014, down from 80 in Q1 2014.
  • Funds reported $379M of Repros Therapeutics Inc. stock for Q2 2014, up 0.1% quarter-over-quarter.
  • 9 funds opened new Repros Therapeutics Inc. positions in Q2 2014 and 12 closed out, a net change of -3 holders.
  • The largest Repros Therapeutics Inc. buyer in Q2 2014 was Sarissa Capital Management, an estimated $7.22M added.
  • The largest Repros Therapeutics Inc. seller in Q2 2014 was PFM Health Sciences, an estimated $4.3M sold.

Based on aggregated 13F filings for Q2 2014.